MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with N

Nefopam

Nefopam 30mg tablets

No stability information

Stability notes for Nefopam 30mg tablets

There are no stability notes for this medicine.

Suppliers (15) of Nefopam 30mg tablets
Nefopam 30mg tablets (A A H Pharmaceuticals Ltd)
Nefopam 30mg tablets (Alliance Healthcare (Distribution) Ltd)
Nefopam 30mg tablets (Brown & Burk UK Ltd)
Nefopam 30mg tablets (Crescent Pharma Ltd)
Nefopam 30mg tablets (Drugsrus Ltd)
Nefopam 30mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Nefopam 30mg tablets (Key Pharmaceuticals Ltd)
Nefopam 30mg tablets (Medihealth (Northern) Ltd)
Nefopam 30mg tablets (Medreich Plc)
Nefopam 30mg tablets (Novumgen Ltd)
Nefopam 30mg tablets (Ria Generics Ltd)
Nefopam 30mg tablets (Rivopharm (UK) Ltd)
Nefopam 30mg tablets (Rudipharm Ltd)
Nefopam 30mg tablets (Teva UK Ltd)
Nefopam 30mg tablets (Tillomed Laboratories Ltd)

Nefopam 60mg tablets

No stability information

Stability notes for Nefopam 60mg tablets

There are no stability notes for this medicine.

Suppliers

Nefopam 60mg tablets (A A H Pharmaceuticals Ltd)
Nefopam 60mg tablets (Alliance Healthcare (Distribution) Ltd)
Nefopam 60mg tablets (Brown & Burk UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.